Study of the Drugs Prescribed on Alzheimer's Disease: from the Insurance Claims Data of Korea National Health Insurance Service |
Kim, Jungeun
(Graduate School of Clinical Pharmacy, Sookmyung Women's University)
Lee, Jonghyuk (National Health Insurance Service) Jeong, Ji Hoon (College of Medicine, Chung-Ang University) Kang, Minku (College of Pharmacy, Woosuk University) Bang, Joon Seok (Graduate School of Clinical Pharmacy, Sookmyung Women's University) |
1 | http://kostat.go.kr/portal/korea/index.action (Accessed on April 27, 2014) |
2 | Annual Reports of Center for Treatment of Dementias in Korea. 2013 |
3 | http://www.edementia.or.kr/main/mainStart (Accessed on May 1, 2014) |
4 | National Plan of Management for Dementia. Korea Ministry of Food and Drug Safety. 2012 |
5 | Katzman R. Education and the prevalence of dementia and Alzheimer's disease among community dwelling elderly persons and their first relatives. Ann Neurol 1993;33:494-501. DOI ScienceOn |
6 | Clinical Therapeutic Guideline for Dementias. Korea Ministry of Food and Drug Safety, 2009 |
7 | Statistical Data of Health Insurance in Korea (2010-2013). Health Insurance Review & Assessment Service in Korea. |
8 | Lee KS, Suh HS. Alzheimer's Disease: Clinical Trials and Future Perspectives. Korean J Psychopharmacol 2012;23 (4):131-5. |
9 | Lee DW. Evidence-Based Treatment of Alzheimer's Disease. J Korean Med Assoc 2009;52(4):417-25. DOI ScienceOn |
10 | NICE technology appraisal guidance 217 Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of NICE technology appraisal guidance 111). 2011 |
11 | Geldmacher DS. Treatment Guidelines for Alzheimer's Disease: Redefining Perceptions in Primary Care. Prim Care Companion J Clin Psychiatry 2007;9(2):113-21. DOI ScienceOn |
12 | Farlow MR, Cummings JL. Effective Pharmacologic Management of Alzheimer's Disease. Am J Med 2007; 120;388-97. DOI ScienceOn |
13 | Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005593. DOI: 10.1002/14651858.CD005593. |
14 | Winblad B, Grossberg G, Frlich L, et al. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Neurology 2007;69 (Suppl 1):S14S22. |
15 | Heo JH, Kim H, Bae HJ, et al. Trend in Treatment of Dementia by Benefit Cost Status based on Health Insurance Review & Assessment Service (HIRA)'s Data from 2003 to 2007. Dementia and Neurocognitive Disorders 2010;9:29-35. |
16 | Kim JM. Current problems and resolutions on the health policies for patients with dementias. Public Administration and Research 2006;7(2):133-50. |
17 | Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. |
18 | Tanna S. Background Paper 6.11 Alzheimer Disease and other Dementias. 2013 |
19 | http://www.alz.org/ Alzheimer's Association of USA (Accessed on 5. 1. 2014) |
20 | National Plan of Management for Dementia. Korea Ministry of Food and Drug Safety. 2009. |
21 | Survey of the Prevalence of Dementia in Korea (2008). Ministry of Health and Welfare |
22 | BUSINESS WIRE. Research and Markets: Global Alzheimer Prevalence and Drugs Demand. April 12, 2011. |
23 | Notice #2013-127 of Korea Ministry of Health and Welfare September 1, 2013. |
24 | Castro DM. The economic cost of Alzheimer's disease family or public-health burden. Dement Neuropsychol 2010;4(4):262-7. DOI |
25 | Overcome of the barriers in Dementias. News clipping of Medical Observer. Feb. 2014. |